Annual Working Capital
$5.90 M
-$29.06 M-83.11%
31 December 2023
Summary:
AIM ImmunoTech annual working capital is currently $5.90 million, with the most recent change of -$29.06 million (-83.11%) on 31 December 2023. During the last 3 years, it has fallen by -$33.30 million (-84.94%). AIM annual working capital is now -89.42% below its all-time high of $55.79 million, reached on 31 December 2009.AIM Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
-$2.53 M
-$4.05 M-266.56%
30 September 2024
Summary:
AIM ImmunoTech quarterly working capital is currently -$2.53 million, with the most recent change of -$4.05 million (-266.56%) on 30 September 2024. Over the past year, it has dropped by -$20.56 million (-114.04%). AIM quarterly working capital is now -104.17% below its all-time high of $60.69 million, reached on 30 September 2009.AIM Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AIM Working Capital Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -83.1% | -114.0% |
3 y3 years | -84.9% | -106.8% |
5 y5 years | +495.4% | -130.0% |
AIM Working Capital High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -88.1% | at low | -105.1% | at low |
5 y | 5 years | -88.1% | +495.4% | -105.0% | at low |
alltime | all time | -89.4% | +495.4% | -104.2% | at low |
AIM ImmunoTech Working Capital History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -$2.53 M(-266.6%) |
June 2024 | - | $1.52 M(+6.2%) |
Mar 2024 | - | $1.43 M(-75.8%) |
Dec 2023 | $5.90 M(-83.1%) | $5.90 M(-67.2%) |
Sept 2023 | - | $18.03 M(-30.6%) |
June 2023 | - | $25.98 M(-17.0%) |
Mar 2023 | - | $31.32 M(-10.4%) |
Dec 2022 | $34.96 M(-29.4%) | $34.96 M(-8.6%) |
Sept 2022 | - | $38.26 M(-14.4%) |
June 2022 | - | $44.68 M(-10.0%) |
Mar 2022 | - | $49.61 M(+0.1%) |
Dec 2021 | $49.54 M(+26.4%) | $49.54 M(+32.9%) |
Sept 2021 | - | $37.27 M(-7.9%) |
June 2021 | - | $40.45 M(-19.5%) |
Mar 2021 | - | $50.25 M(+28.2%) |
Dec 2020 | $39.21 M(+320.7%) | $39.21 M(+0.6%) |
Sept 2020 | - | $38.96 M(+13.5%) |
June 2020 | - | $34.33 M(+18.4%) |
Mar 2020 | - | $29.01 M(+211.3%) |
Dec 2019 | $9.32 M(-724.2%) | $9.32 M(+10.5%) |
Sept 2019 | - | $8.43 M(+320.0%) |
June 2019 | - | $2.01 M(-46.7%) |
Mar 2019 | - | $3.77 M(-352.4%) |
Dec 2018 | -$1.49 M(-287.1%) | -$1.49 M(+7757.9%) |
Sept 2018 | - | -$19.00 K(-100.6%) |
June 2018 | - | $3.21 M(+6.5%) |
Mar 2018 | - | $3.01 M(+277.6%) |
Dec 2017 | $798.00 K(-82.3%) | $798.00 K(-48.0%) |
Sept 2017 | - | $1.53 M(-20.8%) |
June 2017 | - | $1.94 M(-24.2%) |
Mar 2017 | - | $2.55 M(-43.3%) |
Dec 2016 | $4.51 M(-44.6%) | $4.51 M(-34.7%) |
Sept 2016 | - | $6.90 M(+9.5%) |
June 2016 | - | $6.30 M(-2.2%) |
Mar 2016 | - | $6.45 M(-20.8%) |
Dec 2015 | $8.14 M(-32.6%) | $8.14 M(-23.6%) |
Sept 2015 | - | $10.65 M(-23.7%) |
June 2015 | - | $13.96 M(-1.0%) |
Mar 2015 | - | $14.10 M(+16.8%) |
Dec 2014 | $12.07 M(-24.7%) | $12.07 M(-10.0%) |
Sept 2014 | - | $13.41 M(-17.7%) |
June 2014 | - | $16.30 M(-13.8%) |
Mar 2014 | - | $18.90 M(+18.0%) |
Dec 2013 | $16.02 M(-50.1%) | $16.02 M(-15.3%) |
Sept 2013 | - | $18.92 M(-17.8%) |
June 2013 | - | $23.02 M(-19.4%) |
Mar 2013 | - | $28.55 M(-11.0%) |
Dec 2012 | $32.08 M(+20.1%) | $32.08 M(+20.3%) |
Sept 2012 | - | $26.66 M(+15.3%) |
June 2012 | - | $23.13 M(-16.4%) |
Mar 2012 | - | $27.66 M(+3.5%) |
Dec 2011 | $26.72 M(-21.1%) | $26.72 M(-12.7%) |
Sept 2011 | - | $30.62 M(-1.5%) |
June 2011 | - | $31.09 M(-8.1%) |
Mar 2011 | - | $33.84 M(0.0%) |
Dec 2010 | $33.84 M | $33.84 M(-6.5%) |
Sept 2010 | - | $36.19 M(+3.6%) |
June 2010 | - | $34.94 M(-32.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2010 | - | $51.53 M(-7.6%) |
Dec 2009 | $55.79 M(+888.1%) | $55.79 M(-8.1%) |
Sept 2009 | - | $60.69 M(+50.8%) |
June 2009 | - | $40.25 M(+850.9%) |
Mar 2009 | - | $4.23 M(-25.0%) |
Dec 2008 | $5.65 M(-60.8%) | $5.65 M(-17.5%) |
Sept 2008 | - | $6.84 M(-28.9%) |
June 2008 | - | $9.63 M(-19.0%) |
Mar 2008 | - | $11.89 M(-17.5%) |
Dec 2007 | $14.41 M(-13.0%) | $14.41 M(-13.4%) |
Sept 2007 | - | $16.63 M(-15.3%) |
June 2007 | - | $19.64 M(+1.9%) |
Mar 2007 | - | $19.29 M(+16.5%) |
Dec 2006 | $16.56 M(+1.3%) | $16.56 M(+24.8%) |
Sept 2006 | - | $13.27 M(-18.7%) |
June 2006 | - | $16.32 M(-30.4%) |
Mar 2006 | - | $23.44 M(+43.3%) |
Dec 2005 | $16.35 M(+3.9%) | $16.35 M(+105.3%) |
Sept 2005 | - | $7.97 M(-12.0%) |
June 2005 | - | $9.05 M(-22.4%) |
Mar 2005 | - | $11.67 M(-25.9%) |
Dec 2004 | $15.74 M(+124.9%) | $15.74 M(-10.8%) |
Sept 2004 | - | $17.65 M(+83.3%) |
June 2004 | - | $9.63 M(+67.1%) |
Mar 2004 | - | $5.76 M(-17.7%) |
Dec 2003 | $7.00 M(+139.3%) | $7.00 M(+16.8%) |
Sept 2003 | - | $5.99 M(+10.7%) |
June 2003 | - | $5.41 M(+32.9%) |
Mar 2003 | - | $4.07 M(+39.2%) |
Dec 2002 | $2.92 M(-61.2%) | $2.92 M(-16.0%) |
Sept 2002 | - | $3.48 M(-33.7%) |
June 2002 | - | $5.26 M(-14.9%) |
Mar 2002 | - | $6.17 M(-18.0%) |
Dec 2001 | $7.53 M(-0.2%) | $7.53 M(+136.7%) |
Sept 2001 | - | $3.18 M(-27.7%) |
June 2001 | - | $4.41 M(-19.6%) |
Mar 2001 | - | $5.48 M(-27.4%) |
Dec 2000 | $7.55 M(-20.5%) | $7.55 M(-11.7%) |
Sept 2000 | - | $8.55 M(-11.8%) |
June 2000 | - | $9.70 M(-13.1%) |
Mar 2000 | - | $11.16 M(+17.5%) |
Dec 1999 | $9.50 M(-24.6%) | $9.50 M(+63.8%) |
Sept 1999 | - | $5.80 M(-17.1%) |
June 1999 | - | $7.00 M(-26.3%) |
Mar 1999 | - | $9.50 M(-24.6%) |
Dec 1998 | $12.60 M(+35.5%) | $12.60 M(-13.7%) |
Sept 1998 | - | $14.60 M(+117.9%) |
June 1998 | - | $6.70 M(-16.3%) |
Mar 1998 | - | $8.00 M(-14.0%) |
Dec 1997 | $9.30 M(+116.3%) | $9.30 M(+1760.0%) |
Sept 1997 | - | $500.00 K(-75.0%) |
June 1997 | - | $2.00 M(-37.5%) |
Mar 1997 | - | $3.20 M(-25.6%) |
Dec 1996 | $4.30 M(+38.7%) | $4.30 M(-24.6%) |
Sept 1996 | - | $5.70 M(+375.0%) |
June 1996 | - | $1.20 M(-50.0%) |
Mar 1996 | - | $2.40 M(-22.6%) |
Dec 1995 | $3.10 M | $3.10 M |
FAQ
- What is AIM ImmunoTech annual working capital?
- What is the all time high annual working capital for AIM ImmunoTech?
- What is AIM ImmunoTech annual working capital year-on-year change?
- What is AIM ImmunoTech quarterly working capital?
- What is the all time high quarterly working capital for AIM ImmunoTech?
- What is AIM ImmunoTech quarterly working capital year-on-year change?
What is AIM ImmunoTech annual working capital?
The current annual working capital of AIM is $5.90 M
What is the all time high annual working capital for AIM ImmunoTech?
AIM ImmunoTech all-time high annual working capital is $55.79 M
What is AIM ImmunoTech annual working capital year-on-year change?
Over the past year, AIM annual working capital has changed by -$29.06 M (-83.11%)
What is AIM ImmunoTech quarterly working capital?
The current quarterly working capital of AIM is -$2.53 M
What is the all time high quarterly working capital for AIM ImmunoTech?
AIM ImmunoTech all-time high quarterly working capital is $60.69 M
What is AIM ImmunoTech quarterly working capital year-on-year change?
Over the past year, AIM quarterly working capital has changed by -$20.56 M (-114.04%)